Abstract
The appropriate duration of therapy for childhood ALL remains controversial.
82 children(M:F, 47:35) with ALL were diagnosed between 1965-1975. Forty (49%)children, including 18 males,remained in complete continuous remission (CCR) at 3 years. Between the third and fifth years of therapy, 3 males and 3 females relapsed. The sites of initial relapse were the CNS in 5(4 had received CNS prophylaxis) and a simultaneous marrow and testicular relapse in the sixth. Five were initially high risk patients by age(<2 or >8 years)or white count(≥30,000/mm3) criterian. One additional child died, in remission, of varicella complications.
33 patients (40%) remained in CCR at least 5 years. They had received chemotherapy for a median of 61 mos. Followup times off therapy ranged from 6-178 mos (median 36+ mos). One boy in this group subsequently relapsed in the marrow 16 months after therapy ended.
We conclude that the relapse rate of 17.5% (7/40) after 3 years of CCR is comparable to the 20% relapse rate reported by St. Jude Children's Research Hospital (NEJM 300:269, 1979), although our patients received therapy for an additional 2+ years. Continuing therapy beyond 3 years would therefore seem to subject patients to continued potential morbidity without improving ultimate prognosis.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dunn, N., Russell, E., Mcwilliams, N. et al. 805A PROGNOSIS AFTER 3-YEAR SURVIVAL IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL). Pediatr Res 15 (Suppl 4), 576 (1981). https://doi.org/10.1203/00006450-198104001-00830
Issue Date:
DOI: https://doi.org/10.1203/00006450-198104001-00830